Phospholipase D2 (PLD2) Peptide
-
- Target See all Phospholipase D2 (PLD2) products
- Phospholipase D2 (PLD2)
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- DLHYRLTDLG DSSESAASQP PTPRPDSPAT PDLSHNQFFW LGKDYSNLIT
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of PLD2 antibody,
Alternative Names: PLD2 control peptide, PLD2 antibody Blocking Peptide, Anti-PLD2 Blocking Peptide, phospholipase D2 Blocking Peptide, PLD2, PLD-2, PLD 2, PLD-2 Blocking Peptide, PLD 2 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- Phospholipase D2 (PLD2)
- Synonyms
- Pldc Peptide, PLD2 Peptide, phospholipase D2 Peptide, PLD2 Peptide, Pld2 Peptide, pld2 Peptide, CpipJ_CPIJ013122 Peptide, VDBG_00892 Peptide
- Background
- Phosphatidylcholine (PC)-specific phospholipases D (PLDs, EC 3.1.4.4) catalyze the hydrolysis of PC to produce phosphatidic acid and choline. Activation of PC-specific PLDs occurs as a consequence of agonist stimulation of both tyrosine kinase and G protein-coupled receptors. PC-specific PLDs have been proposed to function in regulated secretion, cytoskeletal reorganization, transcriptional regulation, and cell cycle control.
- Molecular Weight
- 106 kDa
-